115 related articles for article (PubMed ID: 14700554)
1. Glucose metabolism and visceral fat in GH deficient adults: 1 year of GH replacement.
Spina LD; Soares DV; Brasil RR; da Silva EM; Lobo PM; Conceição FL; Vaisman M
Growth Horm IGF Res; 2004 Feb; 14(1):45-51. PubMed ID: 14700554
[TBL] [Abstract][Full Text] [Related]
2. Glucose metabolism and visceral fat in GH deficient adults: two years of GH-replacement.
Spina LD; Soares DV; Brasil RR; Lobo PM; Lúcia Conceição F; Vaisman M
Pituitary; 2004; 7(3):123-129. PubMed ID: 16328562
[TBL] [Abstract][Full Text] [Related]
3. A low individualized GH dose in young patients with childhood onset GH deficiency normalized serum IGF-I without significant deterioration in glucose tolerance.
Bülow B; Erfurth EM
Clin Endocrinol (Oxf); 1999 Jan; 50(1):45-55. PubMed ID: 10341855
[TBL] [Abstract][Full Text] [Related]
4. The effect of the deterioration of insulin sensitivity on beta-cell function in growth-hormone-deficient adults following 4-month growth hormone replacement therapy.
Rosenfalck AM; Fisker S; Hilsted J; Dinesen B; Vølund A; Jørgensen JO; Christiansen JS; Madsbad S
Growth Horm IGF Res; 1999 Apr; 9(2):96-105. PubMed ID: 10373342
[TBL] [Abstract][Full Text] [Related]
5. Effect of growth hormone on body composition and visceral adiposity in middle-aged men with visceral obesity.
Pasarica M; Zachwieja JJ; Dejonge L; Redman S; Smith SR
J Clin Endocrinol Metab; 2007 Nov; 92(11):4265-70. PubMed ID: 17785361
[TBL] [Abstract][Full Text] [Related]
6. The effects of recombinant human growth hormone on body composition and glucose metabolism in HIV-infected patients with fat accumulation.
Lo JC; Mulligan K; Noor MA; Schwarz JM; Halvorsen RA; Grunfeld C; Schambelan M
J Clin Endocrinol Metab; 2001 Aug; 86(8):3480-7. PubMed ID: 11502767
[TBL] [Abstract][Full Text] [Related]
7. Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients.
Nam SY; Kim KR; Cha BS; Song YD; Lim SK; Lee HC; Huh KB
Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1101-7. PubMed ID: 11477493
[TBL] [Abstract][Full Text] [Related]
8. Two years of growth hormone replacement therapy in a group of patients with Sheehan's syndrome.
Soares DV; Spina LD; de Lima Oliveira Brasil RR; Lobo PM; Salles E; Coeli CM; Conceição FL; Vaisman M
Pituitary; 2006; 9(2):127-35. PubMed ID: 16944044
[TBL] [Abstract][Full Text] [Related]
9. Comparison of glucose and lipid metabolism and bone mineralization in patients with growth hormone deficiency with and without long-term growth hormone replacement.
Roemmler J; Kuenkler M; Schneider HJ; Dieterle C; Schopohl J
Metabolism; 2010 Mar; 59(3):350-8. PubMed ID: 19800640
[TBL] [Abstract][Full Text] [Related]
10. Long-term monitoring of insulin sensitivity in growth hormone-deficient adults on substitutive recombinant human growth hormone therapy.
Giavoli C; Porretti S; Ronchi CL; Cappiello V; Ferrante E; Orsi E; Arosio M; Beck-Peccoz P
Metabolism; 2004 Jun; 53(6):740-3. PubMed ID: 15164321
[TBL] [Abstract][Full Text] [Related]
11. The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults.
Weaver JU; Monson JP; Noonan K; John WG; Edwards A; Evans KA; Cunningham J
J Clin Endocrinol Metab; 1995 Jan; 80(1):153-9. PubMed ID: 7829604
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone (GH) replacement reduces total body fat and normalizes insulin sensitivity in GH-deficient adults: a report of one-year clinical experience.
Hwu CM; Kwok CF; Lai TY; Shih KC; Lee TS; Hsiao LC; Lee SH; Fang VS; Ho LT
J Clin Endocrinol Metab; 1997 Oct; 82(10):3285-92. PubMed ID: 9329355
[TBL] [Abstract][Full Text] [Related]
13. Persisting effects on fasting glucose levels and insulin sensitivity after 6 months of discontinuation of a very low-dose GH therapy in adults with severe GH deficiency.
Yuen KC; Dunger DB
Clin Endocrinol (Oxf); 2006 May; 64(5):549-55. PubMed ID: 16649975
[TBL] [Abstract][Full Text] [Related]
14. Effects on metabolic variables after 12-month treatment with a new once-a-week sustained-release recombinant growth hormone (GH: LB03002) in patients with GH deficiency.
Roemmler J; Gockel A; Otto B; Bidlingmaier M; Schopohl J
Clin Endocrinol (Oxf); 2012 Jan; 76(1):88-95. PubMed ID: 21682757
[TBL] [Abstract][Full Text] [Related]
15. The effect of 30 months of low-dose replacement therapy with recombinant human growth hormone (rhGH) on insulin and C-peptide kinetics, insulin secretion, insulin sensitivity, glucose effectiveness, and body composition in GH-deficient adults.
Rosenfalck AM; Maghsoudi S; Fisker S; Jørgensen JO; Christiansen JS; Hilsted J; Vølund AA; Madsbad S
J Clin Endocrinol Metab; 2000 Nov; 85(11):4173-81. PubMed ID: 11095450
[TBL] [Abstract][Full Text] [Related]
16. The effects of GH replacement in adult GH-deficient patients: changes in body composition without concomitant changes in the adipokines and insulin resistance.
Hana V; Silha JV; Justova V; Lacinova Z; Stepan JJ; Murphy LJ
Clin Endocrinol (Oxf); 2004 Apr; 60(4):442-50. PubMed ID: 15049958
[TBL] [Abstract][Full Text] [Related]
17. Short-term growth hormone treatment in girls with Turner syndrome decreases fat mass and insulin sensitivity: a randomized, double-blind, placebo-controlled, crossover study.
Gravholt CH; Naeraa RW; Brixen K; Kastrup KW; Mosekilde L; Jørgensen JO; Christiansen JS
Pediatrics; 2002 Nov; 110(5):889-96. PubMed ID: 12415026
[TBL] [Abstract][Full Text] [Related]
18. The effects of short-term administration of two low doses versus the standard GH replacement dose on insulin sensitivity and fasting glucose levels in young healthy adults.
Yuen K; Ong K; Husbands S; Chatelain P; Fryklund L; Gluckman P; Ranke M; Cook D; Rosenfeld R; Wass J; Dunger D
J Clin Endocrinol Metab; 2002 May; 87(5):1989-95. PubMed ID: 11994330
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone (GH) substitution for one year normalizes elevated GH-binding protein levels in GH-deficient adults secondary to a reduction in body fat. A placebo-controlled trial.
Fisker S; Vahl N; Hansen TB; Jørgensen JO; Hagen C; Orskov H; Christiansen JS
Growth Horm IGF Res; 1998 Apr; 8(2):105-12. PubMed ID: 10987677
[TBL] [Abstract][Full Text] [Related]
20. Association of insulin resistance and nocturnal fall of blood pressure in GH-deficient adults during GH replacement.
Brasil RR; Soares DV; Spina LD; Lobo PM; da Silva EM; Mansur VA; Pinheiro MF; Conceição FL; Vaisman M
J Endocrinol Invest; 2007 Apr; 30(4):306-12. PubMed ID: 17556867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
